Pinnacle Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.15M | Buy |
10,808
+325
| +3% | +$34.5K | 0.02% | 477 |
|
2025
Q1 | $1.3M | Sell |
10,483
-100
| -0.9% | -$12.4K | 0.02% | 443 |
|
2024
Q4 | $1.3M | Buy |
10,583
+322
| +3% | +$39.7K | 0.02% | 437 |
|
2024
Q3 | $1.26M | Sell |
10,261
-77
| -0.7% | -$9.47K | 0.02% | 428 |
|
2024
Q2 | $1.1M | Sell |
10,338
-33
| -0.3% | -$3.52K | 0.02% | 451 |
|
2024
Q1 | $1.25M | Buy |
10,371
+110
| +1% | +$13.2K | 0.02% | 447 |
|
2023
Q4 | $1.26M | Sell |
10,261
-326
| -3% | -$40.1K | 0.02% | 435 |
|
2023
Q3 | $1.37M | Buy |
10,587
+238
| +2% | +$30.8K | 0.03% | 411 |
|
2023
Q2 | $1.28M | Buy |
10,349
+1,308
| +14% | +$162K | 0.02% | 430 |
|
2023
Q1 | $1.32M | Buy |
9,041
+3,561
| +65% | +$521K | 0.03% | 368 |
|
2022
Q4 | $873K | Buy |
5,480
+5
| +0.1% | +$797 | 0.02% | 415 |
|
2022
Q3 | $730K | Sell |
5,475
-150
| -3% | -$20K | 0.02% | 445 |
|
2022
Q2 | $878K | Sell |
5,625
-185
| -3% | -$28.9K | 0.02% | 431 |
|
2022
Q1 | $904K | Buy |
5,810
+3,930
| +209% | +$611K | 0.02% | 463 |
|
2021
Q4 | $240K | Buy |
1,880
+141
| +8% | +$18K | ﹤0.01% | 719 |
|
2021
Q3 | $226K | Buy |
1,739
+260
| +18% | +$33.8K | ﹤0.01% | 704 |
|
2021
Q2 | $263K | Buy |
1,479
+139
| +10% | +$24.7K | ﹤0.01% | 677 |
|
2021
Q1 | $220K | Sell |
1,340
-100
| -7% | -$16.4K | ﹤0.01% | 683 |
|
2020
Q4 | $238K | Hold |
1,440
| – | – | ﹤0.01% | 639 |
|
2020
Q3 | $205K | Buy |
+1,440
| New | +$205K | ﹤0.01% | 637 |
|
2020
Q1 | – | Sell |
-1,340
| Closed | -$200K | – | 690 |
|
2019
Q4 | $200K | Buy |
+1,340
| New | +$200K | ﹤0.01% | 667 |
|
2017
Q3 | – | Sell |
-1,380
| Closed | -$215K | – | 679 |
|
2017
Q2 | $215K | Sell |
1,380
-240
| -15% | -$37.4K | ﹤0.01% | 630 |
|
2017
Q1 | $235K | Buy |
+1,620
| New | +$235K | ﹤0.01% | 603 |
|
2016
Q4 | – | Sell |
-1,802
| Closed | -$219K | – | 640 |
|
2016
Q3 | $219K | Sell |
1,802
-115
| -6% | -$14K | ﹤0.01% | 587 |
|
2016
Q2 | $271K | Sell |
1,917
-130
| -6% | -$18.4K | 0.01% | 554 |
|
2016
Q1 | $267K | Sell |
2,047
-40
| -2% | -$5.22K | 0.01% | 538 |
|
2015
Q4 | $293K | Sell |
2,087
-93
| -4% | -$13.1K | 0.01% | 541 |
|
2015
Q3 | $290K | Sell |
2,180
-50
| -2% | -$6.65K | 0.01% | 531 |
|
2015
Q2 | $393K | Sell |
2,230
-20
| -0.9% | -$3.53K | 0.01% | 502 |
|
2015
Q1 | $389K | Buy |
2,250
+135
| +6% | +$23.3K | 0.01% | 507 |
|
2014
Q4 | $346K | Buy |
+2,115
| New | +$346K | 0.01% | 507 |
|